HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young Ji Yoo Selected Research

Insulin Receptor

10/2018β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young Ji Yoo Research Topics

Disease

2Colonic Neoplasms (Colon Cancer)
10/2019 - 10/2018
2Neoplasms (Cancer)
10/2019 - 10/2018
1Cryptococcosis
11/2018
1Infections
11/2018
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2011

Drug/Important Bio-Agent (IBA)

1Monounsaturated Fatty AcidsIBA
10/2019
1LipidsIBA
10/2019
1Fluconazole (Zonal)FDA LinkGeneric
11/2018
19-deoxo-31-O-demethyl-FK506IBA
11/2018
1Biomarkers (Surrogate Marker)IBA
10/2018
1Tyrosine Kinase InhibitorsIBA
10/2018
1CateninsIBA
10/2018
1Insulin ReceptorIBA
10/2018
1Insulin-Like PeptidesIBA
10/2018
12,3-dihydrotrichostatin AIBA
05/2011
1Cytostatic AgentsIBA
05/2011
1trichostatin A (A 300)IBA
05/2011